MM #274: Stocks That Benefit From Trump, Nvidia’s Top Risk, Ozempic $2B Lawsuits, & September Market Strategy
This week’s Market Mondays is packed with high-level investing questions and timely market insights. We break down which five companies could thrive under a Trump administration, discuss whether Nvidia has […]